Endothelial progenitor cells: Quo Vadis?

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 2, 2011, Pages 266-272

  Richardson, Matthew R ^a   Yoder, Mervin C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Endothelial progenitor cell (EPC)

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; FIBRONECTIN; LECTIN; LIPOPROTEIN; MEMBRANE ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD VESSEL INJURY; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURFACE; COLONY FORMATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; ISCHEMIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

ANIMALS; CELL SEPARATION; ENDOTHELIAL CELLS; HUMANS; STEM CELLS; TERMINOLOGY AS TOPIC;

MURINAE;

EID: 78649872095     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.07.009     Document Type: Review

References (76)

1. Schwartz S.M., Gajdusek C.M., Selden S.C. Vascular wall growth control: the role of the endothelium. Arteriosclerosis 1981, 1(2):107-126.
2. Kunz J., Schreiter B., Schubert B., Voss K., Krieg K. Experimental investigations on the regeneration of aortic endothelial cells. Automatic and visual evaluation of autoradiograms (author's transl). Acta Histochem 1978, 61(1):53-63.
3. Malczak H.T., Buck R.C. Regeneration of endothelium in rat aorta after local freezing. A scanning electron microscopic study. Am J Pathol 1977, 86(1):133-148.
4. Schwartz S.M., Gajdusek C.M., Reidy M.A., Selden S.C., Haudenschild C.C. Maintenance of integrity in aortic endothelium. Fed Proc 1980, 39(9):2618-2625.
5. Schwartz S.M., Stemerman M.B., Benditt E.P. The aortic intima. II. Repair of the aortic lining after mechanical denudation. Am J Pathol 1975, 81(1):15-42.
6. Caplan B.A., Schwartz C.J. Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis 1973, 17(3):401-417.
7. Haudenschild C., Studer A. Early interactions between blood cells and severely damaged rabbit aorta. Eur J Clin Invest 1971, 2(1):1-7.
8. Haudenschild C.C., Schwartz S.M. Endothelial regeneration. II. Restitution of endothelial continuity. Lab Invest 1979, 41(5):407-418.
9. Taylor R.G., Lewis J.C. Endothelial cell proliferation and monocyte adhesion to atherosclerotic lesions of white carneau pigeons. Am J Pathol 1986, 125(1):152-160.
10. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
11. Gupta R., Tongers J., Losordo D.W. Human studies of angiogenic gene therapy. Circ Res 2009, 105(8):724-736.
12. Moreno P.R., Sanz J., Fuster V. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol 2009, 53(25):2315-2323.
13. Pacilli A., Faggioli G., Stella A., Pasquinelli G. An update on therapeutic angiogenesis for peripheral vascular disease. Ann Vasc Surg 2010, 24(2):258-268.
14. Tongers J., Roncalli J.G., Losordo D.W. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 2010, 79(3):200-206.
15. Jujo K., Ii M., Losordo D.W. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 2008, 45(4):530-544.
16. Sekiguchi H., Ii M., Losordo D.W. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol 2009, 219(2):235-242.
17. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353(10):999-1007.
18. Zeoli A., Dentelli P., Brizzi M.F. Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders. J Endocrinol Invest 2009, 32(4):370-382.
19. Dimmeler S., Zeiher A.M. Cell therapy of acute myocardial infarction: open questions. Cardiology 2009, 113(3):155-160.
20. George J.C. Stem cell therapy in acute myocardial infarction: a review of clinical trials. Transl Res 2010, 155(1):10-19.
21. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008, 29(15):1807-1818.
22. Steinmetz M., Nickenig G., Werner N. Endothelial-regenerating cells: an expanding universe. Hypertension 2010, 55(3):593-599.
23. Yoder M.C., Ingram D.A. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol 2009, 16(4):269-273.
24. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000, 97(7):3422-3427.
25. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5(4):434-438.
26. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-E7.
27. Assmus B., Rolf A., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., et al. Clinical outcome 2years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010, 3(1):89-96.
28. Chavakis E., Urbich C., Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 2008, 45(4):514-522.
29. Kovacic J.C., Harvey R.P., Dimmeler S. Cardiovascular regenerative medicine: digging in for the long haul. Cell Stem Cell 2007, 1(6):628-633.
30. Urbich C., Rossig L., Dimmeler S. Restoration of cardiac function with progenitor cells. Novartis Found Symp 2006, 274:214-223. discussion 23-7, 72-6.
31. Abdul-Salam F., Mansour M.H., Al-Shemary T. The selective expression of distinct fucosylated glycoproteins on murine T and B lymphocyte subsets. Immunobiology 2005, 210(9):695-708.
32. Baldus S.E., Thiele J., Charles A., Hanisch F.G., Fischer R. Carbohydrate antigens of human megakaryocytes and platelet glycoproteins: a comparative study. Histochemistry 1994, 102(3):205-211.
33. Chionh Y.T., Wee J.L., Every A.L., Ng G.Z., Sutton P. M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens. Infect Immun 2009, 77(7):2962-2970.
34. Gao X., Chen J., Tao W., Zhu J., Zhang Q., Chen H., et al. UEA I-bearing nanoparticles for brain delivery following intranasal administration. Int J Pharm 2007, 340(1-2):207-215.
35. Georgiou S., Pasmatzi E., Monastirli A., Sakkis T., Alachioti S., Tsambaos D. Age-related alterations in the carbohydrate residue composition of the cell surface in the unexposed normal human epidermis. Gerontology 2005, 51(3):155-160.
36. Kobayashi N., Matsuzaki O., Shirai S., Aoki I., Yao M., Nagashima Y. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol 2008, 39(9):1350-1359.
37. Schmitz B., Thiele J., Otto F., Theile-Ochel S., Heedt T., Zensen U., et al. Interactions between endogeneous lectins and fucosylated oligosaccharides in megakaryocyte-dependent fibroblast growth of the normal bone marrow. Leukemia 1996, 10(10):1604-1614.
38. Thom I., Schult-Kronefeld O., Burkholder I., Goern M., Andritzky B., Blonski K., et al. Lectin histochemistry of metastatic adenocarcinomas of the lung. Lung Cancer 2007, 56(3):391-397.
39. Zhang S.J., Zhang H., Wei Y.J., Su W.J., Liao Z.K., Hou M., et al. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 2006, 16(6):577-584.
40. Prokopi M., Pula G., Mayr U., Devue C., Gallagher J., Xiao Q., et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009, 114(3):723-732.
41. Hassan N.F., Campbell D.E., Douglas S.D. Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods 1986, 95(2):273-276.
42. Schmeisser A., Garlichs C.D., Zhang H., Eskafi S., Graffy C., Ludwig J., et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 2001, 49(3):671-680.
43. Schmeisser A., Graffy C., Daniel W.G., Strasser R.H. Phenotypic overlap between monocytes and vascular endothelial cells. Adv Exp Med Biol 2003, 522:59-74.
44. Medina R.J., O'Neill C.L., Sweeney M., Guduric-Fuchs J., Gardiner T.A., Simpson D.A., et al. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics 2010, 3(1):18.
45. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95(3):952-958.
46. Bertolini F., Mancuso P., Braidotti P., Shaked Y., Kerbel R.S. The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer. Biochim Biophys Acta 2009, 1796(1):27-32.
47. Case J., Mead L.E., Bessler W.K., Prater D., White H.A., Saadatzadeh M.R., et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007, 35(7):1109-1118.
48. Estes M.L., Mund J.A., Ingram D.A., Case J. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Curr Protoc Cytom 2010, 1-11. Chapter 9: Unit 9 33.
49. Timmermans F., Van Hauwermeiren F., De Smedt M., Raedt R., Plasschaert F., De Buyzere M.L., et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007, 27(7):1572-1579.
50. Bertolini F., Mancuso P., Kerbel R.S. Circulating endothelial progenitor cells. N Engl J Med 2005, 353(24):2613-2616. author reply -6.
51. Gao D., Nolan D.J., Mellick A.S., Bambino K., McDonnell K., Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319(5860):195-198.
52. Nolan D.J., Ciarrocchi A., Mellick A.S., Jaggi J.S., Bambino K., Gupta S., et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007, 21(12):1546-1558.
53. Aicher A., Rentsch M., Sasaki K., Ellwart J.W., Fandrich F., Siebert R., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007, 100(4):581-589.
54. Hagensen M.K., Shim J., Thim T., Falk E., Bentzon J.F. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010, 121(7):898-905.
55. Hillebrands J.L., Klatter F.A., van Dijk W.D., Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002, 8(3):194-195.
56. Perry T.E., Song M., Despres D.J., Kim S.M., San H., Yu Z.X., et al. Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction. Cardiovasc Res 2009, 84(2):317-325.
57. Purhonen S., Palm J., Rossi D., Kaskenpaa N., Rajantie I., Yla-Herttuala S., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 2008, 105(18):6620-6625.
58. Estes M.L., Mund J.A., Mead L.E., Prater D.N., Cai S., Wang H., et al. Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytom A 2010, [ePub ahead of print].
59. Ito H., Miyake M., Nishitani E., Mori K., Hatano T., Okuda T., et al. Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima. Cancer Lett 1999, 143(1):5-13.
60. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348(7):593-600.
61. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104(9):2752-2760.
62. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000, 105(1):71-77.
63. Ingram D.A., Mead L.E., Moore D.B., Woodard W., Fenoglio A., Yoder M.C. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105(7):2783-2786.
64. Au P., Daheron L.M., Duda D.G., Cohen K.S., Tyrrell J.A., Lanning R.M., et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111(3):1302-1305.
65. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109(5):1801-1809.
66. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109(11):4761-4768.
67. Rohde E., Bartmann C., Schallmoser K., Reinisch A., Lanzer G., Linkesch W., et al. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 2007, 25(7):1746-1752.
68. Rohde E., Malischnik C., Thaler D., Maierhofer T., Linkesch W., Lanzer G., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006, 24(2):357-367.
69. Sieveking D.P., Buckle A., Celermajer D.S., Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008, 51(6):660-668.
70. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24(2):288-293.
71. Mukai N., Akahori T., Komaki M., Li Q., Kanayasu-Toyoda T., Ishii-Watabe A., et al. A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res 2008, 314(3):430-440.
72. Coffelt S.B., Lewis C.E., Naldini L., Brown J.M., Ferrara N., De Palma M. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol 2010, 176(4):1564-1576.
73. Pucci F., Venneri M.A., Biziato D., Nonis A., Moi D., Sica A., et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009, 114(4):901-914.
74. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, [ePub ahead of print].
75. Dubois C., Liu X., Claus P., Marsboom G., Pokreisz P., Vandenwijngaert S., et al. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol 2010, 55(20):2232-2243.
76. Medina R., O'Neill C.L., Humphreys M.W., Gardiner T.A., Stitt A.W. Outgrowth endothelial cells: characterization and their potential for reversing ischaemic retinopathy. Invest Opthalmol Vis Sci 2010, [epub ahead of print].